NeurAxis Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for NeurAxis.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 22 Dec 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 12 | N/A | N/A | N/A | 1 |
12/31/2023 | 2 | -15 | -7 | -7 | N/A |
9/30/2023 | 3 | -10 | -4 | -4 | N/A |
6/30/2023 | 3 | -7 | -2 | -2 | N/A |
3/31/2023 | 3 | -7 | -3 | -3 | N/A |
12/31/2022 | 3 | -6 | -2 | -2 | N/A |
9/30/2022 | 3 | -6 | -2 | -2 | N/A |
12/31/2021 | 3 | -4 | -2 | -2 | N/A |
12/31/2020 | 2 | -4 | -4 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NRXS's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if NRXS's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NRXS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NRXS's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if NRXS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NRXS's Return on Equity is forecast to be high in 3 years time